I can understand the excitement. This company did not need to raise capital to progress into a solid profit mode and a good SP. They had $800,000 and were moving into ongoing profitability.
The fact that they have decided to raise capital indicates (to me, anyway) that they believe they can promote Hepafat and complete the fibrositis test and perhaps also develop their new (as yet undisclosed) product. This has got to be significantly profitable more quickly than just poking along on their growing income stream.
It will be boring with a flattish SP for a couple of months, but after that we should see huge benefits. I sure hope they keep us updated regularly on progress.
RHT Price at posting:
5.2¢ Sentiment: Buy Disclosure: Held
